Cancer therapy is moving fast towards more personalized therapies, and the ultimate therapy in this sense is CAR-T-therapy, designed for a single patient, and using the patient’s own cells to mount a powerful defence against cancer.
The CellFit project seek to address one of the biggest challenges for cell-based cancer therapy – efficient and scalable production, and now invite you to an existing seminar, to look closer into research needed to develop such therapies.
We will look closer at how CAR-T-therapies are developed, produced and tested.
How can CAR-T-therapies be developed to benefit patients with other cancers, especially solid tumors?
Can in vitro approaches be used to better predict the effect of cell therapies in the body?
For more information, have a look at the Oslo Cancer Cluster´s webpage.
